Teladoc Health, Inc. (NYSE:TDOC) Stock Now Rated “Hold” by Sell-Side Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been assigned a consensus recommendation of “Hold” from the sixteen ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $7.54.

A number of brokerages have commented on TDOC. Canaccord Genuity Group decreased their price target on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Bank of America raised their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Finally, Citigroup dropped their price target on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd.

Read Our Latest Research Report on Teladoc Health

Insider Activity at Teladoc Health

In other news, CEO Charles III sold 17,805 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the transaction, the chief executive officer owned 465,535 shares in the company, valued at $2,839,763.50. This trade represents a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors have recently bought and sold shares of the stock. ABS Direct Equity Fund LLC purchased a new position in Teladoc Health during the 2nd quarter worth $1,513,000. WINTON GROUP Ltd grew its stake in shares of Teladoc Health by 402.4% in the 2nd quarter. WINTON GROUP Ltd now owns 227,100 shares of the health services provider’s stock worth $1,926,000 after acquiring an additional 181,900 shares in the last quarter. Nykredit A S purchased a new stake in shares of Teladoc Health in the second quarter valued at about $27,000. HighTower Advisors LLC raised its holdings in shares of Teladoc Health by 20.8% in the second quarter. HighTower Advisors LLC now owns 16,808 shares of the health services provider’s stock valued at $143,000 after purchasing an additional 2,893 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Teladoc Health in the second quarter valued at about $1,447,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $6.10 on Friday. The stock has a market capitalization of $1.11 billion, a PE ratio of -6.16 and a beta of 2.12. Teladoc Health has a 52 week low of $4.40 and a 52 week high of $9.89. The stock has a 50 day moving average price of $6.90 and a two-hundred day moving average price of $6.84.

Teladoc Health (NYSE:TDOC – Get Free Report) last issued its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same period in the prior year, the firm earned ($0.19) earnings per share. Teladoc Health’s revenue for the quarter was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. Research analysts forecast that Teladoc Health will post -0.92 EPS for the current year.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company’s offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.

Featured Stories

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.